Does NINTEDANIB Cause Lung neoplasm malignant? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Lung neoplasm malignant have been filed in association with NINTEDANIB. This represents 0.5% of all adverse event reports for NINTEDANIB.
135
Reports of Lung neoplasm malignant with NINTEDANIB
0.5%
of all NINTEDANIB reports
54
Deaths
55
Hospitalizations
How Dangerous Is Lung neoplasm malignant From NINTEDANIB?
Of the 135 reports, 54 (40.0%) resulted in death, 55 (40.7%) required hospitalization, and 10 (7.4%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does NINTEDANIB Cause?
Diarrhoea (9,103)
Nausea (4,198)
Dyspnoea (3,080)
Decreased appetite (2,832)
Death (2,790)
Weight decreased (2,628)
Vomiting (2,524)
Fatigue (2,511)
Cough (2,193)
Idiopathic pulmonary fibrosis (1,905)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which NINTEDANIB Alternatives Have Lower Lung neoplasm malignant Risk?
NINTEDANIB vs NINTEDANIB ESYLATE
NINTEDANIB vs NIRAPARIB
NINTEDANIB vs NIRMATRELVIR\RITONAVIR
NINTEDANIB vs NIROGACESTAT
NINTEDANIB vs NIROGACESTAT HYDROBROMIDE